Stockscreener 앱 받기
10.70
5.06%
-0.565
전일 마감가:
$11.26
열려 있는:
$11.14
하루 거래량:
512.95K
Relative Volume:
0.71
시가총액:
$754.21M
수익:
$133.62M
순이익/손실:
$-177.37M
주가수익비율:
-3.7007
EPS:
-2.89
순현금흐름:
$23.50M
1주 성능:
+0.85%
1개월 성능:
+23.01%
6개월 성능:
-50.33%
1년 성능:
-55.66%
1일 변동 폭
$10.47
$11.14
1주일 범위
$10.29
$11.70
52주 변동 폭
$7.16
$27.24
Xencor Inc Stock (XNCR) Company Profile
명칭
Xencor Inc
전화
626-305-5900
주소
465 N. HALSTEAD ST., PASADENA, CA
XNCR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XNCR
Xencor Inc
|
10.67 | 754.21M | 133.62M | -177.37M | 23.50M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.54 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.00 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
654.29 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
269.17 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
253.97 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-21 | 개시 | William Blair | Outperform |
| 2024-12-12 | 개시 | Wells Fargo | Overweight |
| 2024-12-02 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-04-16 | 재확인 | BTIG Research | Buy |
| 2024-02-28 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-05-19 | 개시 | BofA Securities | Buy |
| 2022-12-06 | 개시 | Cowen | Outperform |
| 2022-10-13 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2022-09-21 | 개시 | JP Morgan | Overweight |
| 2022-07-06 | 재개 | Canaccord Genuity | Buy |
| 2022-02-11 | 개시 | BMO Capital Markets | Outperform |
| 2022-01-21 | 개시 | SMBC Nikko | Outperform |
| 2021-12-15 | 개시 | H.C. Wainwright | Buy |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2021-02-24 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-03-04 | 개시 | Barclays | Underweight |
| 2020-02-25 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-01-30 | 개시 | RBC Capital Mkts | Outperform |
| 2019-11-20 | 재개 | Guggenheim | Neutral |
| 2019-08-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-08-07 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-06-13 | 개시 | Mizuho | Buy |
| 2019-04-12 | 개시 | Guggenheim | Buy |
| 2019-03-27 | 개시 | Berenberg | Buy |
| 2019-03-15 | 개시 | Raymond James | Outperform |
| 2018-09-10 | 재개 | BTIG Research | Buy |
| 2018-03-28 | 재개 | Leerink Partners | Outperform |
| 2017-03-02 | 개시 | Instinet | Neutral |
| 2017-03-02 | 재확인 | Wedbush | Outperform |
| 2016-10-04 | 개시 | Piper Jaffray | Overweight |
| 2015-12-22 | 개시 | Canaccord Genuity | Buy |
| 2015-08-05 | 재확인 | MLV & Co | Buy |
| 2015-02-12 | 재확인 | Oppenheimer | Outperform |
| 2015-01-28 | 재확인 | MLV & Co | Buy |
| 2014-07-11 | 개시 | Oppenheimer | Outperform |
모두보기
Xencor Inc 주식(XNCR)의 최신 뉴스
(XNCR) Technical Data - news.stocktradersdaily.com
Xencor (NASDAQ:XNCR) Earns Outperform Rating from Wedbush - Defense World
Healthy Upside Potential: Xencor Inc (XNCR) - Sete News
Xencor reports positive trial results for inflammatory bowel disease treatment - MSN
Will Xencor (XNCR) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance
Wells Fargo & Company MN Raises Stock Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Analyzing Xencor Inc (XNCR) After Recent Trading Activity - knoxdaily.com
Trading Day Triumph: Xencor Inc (XNCR) Ends at 10.58, a -0.19 Surge/Plunge - DWinneX
Is Xencor Inc (XNCR) a good investment opportunity? - uspostnews.com
Xencor Announces Promising Phase 1 Study Results - TipRanks
Raymond James Financial Inc. Invests $2.33 Million in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor (XNCR) Reports Promising Results and Advances XmAb942 Stu - GuruFocus
Xencor Announces Positive Interim Results From First-in-Human Healthy Volunteer Study of XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, in Development for Treatment of Inflammatory Bowel Disease - BioSpace
Xencor posts trial data for bowel disease drug (XNCR:NASDAQ) - Seeking Alpha
Xencor advances ulcerative colitis treatment into Phase 2b study - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
Is Xencor (NASDAQ:XNCR) A Risky Investment? - simplywall.st
LPL Financial LLC Has $452,000 Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Gaining Ground: Xencor Inc (XNCR) Closes Higher at 10.87, Up 2.07 - DWinneX
It is Poised to be a Bull Market for Xencor Inc (XNCR) - Sete News
Equities Analysts Issue Forecasts for Xencor Q1 Earnings - Defense World
Is the Xencor Inc (NASDAQ:XNCR) stock an investment opportunity? - uspostnews.com
Invesco Ltd. Sells 156,130 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
JPMorgan Chase & Co. Sells 9,291 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor Inc Shares Are Up -44.42% Since The Beginning Of The Year - Marketing Sentinel
Xencor Inc (XNCR) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Xencor (NASDAQ:XNCR) Now Covered by Analysts at William Blair - Defense World
William Blair Initiates Coverage of Xencor (XNCR) with Outperform Recommendation - Nasdaq
William Blair starts Xencor stock with Outperform rating By Investing.com - Investing.com Canada
Xencor Reports Fourth Quarter and Full Year 2024 Financial Results - ADVFN
Xencor (XNCR) Receives Outperform Rating from William Blair | XN - GuruFocus
William Blair starts Xencor stock with Outperform rating - Investing.com
Xencor (XNCR) Receives Outperform Rating from William Blair | XNCR Stock News - GuruFocus
Xencor, Inc. (NASDAQ:XNCR) Given Consensus Rating of “Buy” by Analysts - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Alliancebernstein L.P. - Defense World
Geode Capital Management LLC Acquires 179,526 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
Wellington Management Group LLP Purchases Shares of 27,491 Xencor, Inc. (NASDAQ:XNCR) - The AM Reporter
27,491 Shares in Xencor, Inc. (NASDAQ:XNCR) Acquired by Wellington Management Group LLP - Defense World
Xencor CFO sells $30,232 in company stock By Investing.com - Investing.com India
Xencor CFO sells $30,232 in company stock - Investing.com
Xencor CFO Cornelissen sells $30,232 in company stock - Investing.com
Xencor CFO Cornelissen sells $30,232 in company stock By Investing.com - Investing.com UK
Xencor (NASDAQ:XNCR) Sets New 1-Year LowHere's Why - MarketBeat
Xencor, Inc.: No Major Near Term Catalysts (NASDAQ:XNCR) - Seeking Alpha
Xencor (XNCR) Upgraded to Buy: Here's Why - Yahoo Finance
Federal Circuit’s Xencor Decision: Considerations for Jepson Claims and Implications for 35 U.S.C. § 101 Analysis - NatLawReview.com
Xencor’s SWOT analysis: biotech stock faces pivotal year ahead By Investing.com - Investing.com Canada
Xencor’s SWOT analysis: biotech stock faces pivotal year ahead - Investing.com India
American Century Companies Inc. Has $2.63 Million Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares Bought by Vanguard Group Inc. - Defense World
KLP Kapitalforvaltning AS Invests $280,000 in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor Inc (XNCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Xencor Inc 주식 (XNCR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Cornelissen Bart Jan | SR. VICE PRESIDENT & CFO |
Apr 10 '25 |
Sale |
8.06 |
3,750 |
30,233 |
61,348 |
0.03%
0.49%
자본화:
|
볼륨(24시간):